La Jolla, California-based Avidity Biosciences, a biotechnology company, has secured $100 million in Series C financing. RTW Investments led the round. In addition to the funding, Dr. Roderick T. Wong, a managing partner of RTW Investments, will join Avidity Biosciences’ board of directors.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.